Indications and Alternatives to Hysterectomy

M Jonathan Solnik, MJ Solnik, Malcolm G Munro
Clinical obstetrics and gynecology · 2014 · vol. 57(1) , pp. 14–42 · doi:10.1097/grf.0000000000000010 · PMID:24488051 · W2314482093
review OA: closed CC0 ⤵ 6 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Hysterectomy, though effective for abnormal uterine bleeding, has seen a decline due to improved understanding and minimally invasive options, with alternatives suitable for most women over 40, but its use for chronic pelvic pain is cautioned against until etiology is clear.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Hysterectomy remains one the most common procedures performed in North America. Because of a better understanding of a wide array of disease states and with emerging, more focused minimally invasive treatment options, a relative decline has been documented in the last several years. Although hysterectomy will ultimately eliminate all potential sources of abnormal uterine bleeding, various pharmacologic and surgical alternatives exist that may provide comparable benefit to the majority of women, especially if older than 40 years. Women experiencing chronic pelvic pain; however, should be counseled against hysterectomy until a more clear etiology has been identified.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

MeSH descriptors

Aromatase Inhibitors Hysterectomy Hysteroscopy Levonorgestrel Uterine Artery Embolization Uterine Diseases Uterine Myomectomy Adenomyosis Adenomyosis Aromatase Inhibitors Chronic Pain Chronic Pain Endometrial Hyperplasia Endometrial Hyperplasia Endometriosis Endometriosis Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (45)

Cited by (6)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:40.923139+00:00
License: CC0 · commercial use OK